Genetic testing company NextGxDx has been awarded a group purchasing agreement from health services company Novation.
Through the deal, terms of which were not disclosed, members of the Children's Hospital Association affiliated with Novation will have access to NextGxDx's GeneGonnect testing solution. Members will also have access to resources available through the Nashville company's collaboration with Seattle Children's Hospital PLUGS program, a laboratory management service.
“NextGxDx is proud to partner with several CHA member hospitals already, and we look forward to working with the remaining CHA hospitals served by Novation to implement the joint PLUGS/GeneConnect UM solution,” said NextGxDx CEO Mark Harris. “GeneConnect customers have seen annual savings opportunities of 20 percent to 25 percent, and with the incorporation of the PLUGS program, we see the opportunity for even greater cost savings.”
POSTDATA: WARRANTY DEEDS